Colin Foster
Vorstandsvorsitzender bei iSci Management LLC
Aktive Positionen von Colin Foster
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of New Haven | Vorsitzender | - | - |
iSci Management LLC
iSci Management LLC Miscellaneous Commercial ServicesCommercial Services iSci Management LLC provides business management services. Its services include corporate strategy consulting, interim leadership services, transaction advisory, venture origination and fund-raising. The company is headquartered in New Haven, CT. | Direktor/Vorstandsmitglied | 01.01.2011 | - |
Vorstandsvorsitzender | - | - | |
Corporate Officer/Principal | - | - | |
Vista Life Innovations, Inc. | Direktor/Vorstandsmitglied | - | - |
Cytosolix, Inc.
Cytosolix, Inc. Miscellaneous Commercial ServicesCommercial Services Cytosolix, Inc. is a company that provides products or services related to the field of life sciences or biotechnology. The company is based in Tolland, CT. Foster. The company was founded by Colin J. | Vorsitzender | - | - |
Gründer | - | - | |
Ascendia Pharmaceuticals, Inc.
Ascendia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ascendia Pharmaceuticals LLC engages in the invention and development of specialty pharmaceutical products and novel formulation technologies. It offers rapid development and special development programs. The company was founded by Jingjun Huang in 2012 and is headquartered in North Brunswick, NJ. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Colin Foster
Ehemalige bekannte Positionen von Colin Foster
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Direktor/Vorstandsmitglied | 01.01.2015 | 31.08.2017 |
Vorstandsvorsitzender | 01.01.2015 | - | |
Präsident | 01.01.2015 | - | |
Ivenix, Inc.
Ivenix, Inc. Medical SpecialtiesHealth Technology Ivenix, Inc. operates as a medical device company. It develops and supplies infusion systems and intravenous-infusion pumps that eliminate air in the fluid bag line. The company was founded by John L. Bakos and Jeffrey Carlisle in 2007 and is headquartered in Amesbury, MA. | Vorsitzender | 01.01.2014 | 01.08.2015 |
Optherion, Inc.
Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Direktor/Vorstandsmitglied | 01.01.2005 | 01.01.2012 |
Vorstandsvorsitzender | 01.01.2005 | 01.01.2012 | |
Gründer | 01.01.2005 | 01.01.2012 | |
Präsident | 01.01.2005 | 01.01.2012 | |
CARDIFF ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 04.04.2006 | 28.11.2006 |
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Colin Foster
University of Toronto | Undergraduate Degree |
University of Western Ontario | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 11 |
Kanada | 4 |
Deutschland | 2 |
Operativ
Director/Board Member | 6 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 3 |
Sektoral
Health Technology | 9 |
Consumer Services | 4 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CARDIFF ONCOLOGY, INC. | Health Technology |
BAYER AG | Health Technology |
Private Unternehmen | 10 |
---|---|
Optherion, Inc.
Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Health Technology |
Bayer Pharmaceuticals Corp. | |
Sandoz Canada, Inc.
Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Health Technology |
Ivenix, Inc.
Ivenix, Inc. Medical SpecialtiesHealth Technology Ivenix, Inc. operates as a medical device company. It develops and supplies infusion systems and intravenous-infusion pumps that eliminate air in the fluid bag line. The company was founded by John L. Bakos and Jeffrey Carlisle in 2007 and is headquartered in Amesbury, MA. | Health Technology |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Health Technology |
iSci Management LLC
iSci Management LLC Miscellaneous Commercial ServicesCommercial Services iSci Management LLC provides business management services. Its services include corporate strategy consulting, interim leadership services, transaction advisory, venture origination and fund-raising. The company is headquartered in New Haven, CT. | Commercial Services |
Vista Life Innovations, Inc. | |
The Jackson Laboratory
The Jackson Laboratory BiotechnologyHealth Technology The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME. | Health Technology |
Cytosolix, Inc.
Cytosolix, Inc. Miscellaneous Commercial ServicesCommercial Services Cytosolix, Inc. is a company that provides products or services related to the field of life sciences or biotechnology. The company is based in Tolland, CT. Foster. The company was founded by Colin J. | Commercial Services |
Ascendia Pharmaceuticals, Inc.
Ascendia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ascendia Pharmaceuticals LLC engages in the invention and development of specialty pharmaceutical products and novel formulation technologies. It offers rapid development and special development programs. The company was founded by Jingjun Huang in 2012 and is headquartered in North Brunswick, NJ. | Health Technology |
- Börse
- Insiders
- Colin Foster
- Erfahrung